Business Wire

ADVA

Share
Vodafone Romania uses ADVA NOS in trial of DCSG

ADVA (FSE: ADV) today announced that Vodafone Romania is using its carrier-grade network operating system (NOS) in a key trial of disaggregated cell site gateway (DCSG) technology in a live nationwide network. Built with ADVA’s Ensemble Activator software running on Edgecore’s new family of DCSG devices, the open multi-vendor transport network succeeded in carrying 2G, 3G, 4G and 5G traffic while also interoperating with Vodafone’s existing infrastructure. The trial is a key step towards Vodafone validating the disaggregated model.

“We are pleased to contribute to the innovation in the field of open telecom networks, facilitating the validation of the open cell site gateway concept in a live network scenario while following our existing standard practices and processes. It was a smooth introduction, proving that the concept of open telecom networks where hardware is decoupled from software is feasible – not only in core network platforms through virtualization and in mobile radio access networks through the OpenRAN, but now also in the IP transport layer,” said Catalin Buliga, CTO, Vodafone Romania. “Mobile networks have been for years locked into a limited number of traditional telecom equipment vendors. By investing in developing open networks, where the hardware and software are decoupled, we open the gate to a wide range of suppliers for hardware, a wide range of suppliers for software, we accelerate innovation and increase our resilience.”

By using ADVA and Edgecore’s technology in a complete and fully tested DCSG offering, the trial gives Vodafone Romania insight into new mobile transport opportunities. Developed within the Telecom Infra Project’s Open Optical & Packet Transport group, the solution provides an open, agile and scalable solution able to meet today’s protocol requirements and is adaptable with future needs. Its hardware-supported SyncE and IEEE 1588 timing, with optional SFP-based GNSS backup, fulfills the most stringent synchronization accuracy requirements.

“This latest trial highlights how major mobile network operators have an alternative simple and cost-effective route to the deployment for 5G services. Our open and feature-rich Ensemble Activator NOS and Edgecore’s high-performance white boxes free network operators from closed proprietary systems. They enable them to deploy vendor-neutral disaggregated architectures using best-in-class components,” commented Eli Angel, VP, product line management, ADVA. “Today’s customers expect vendors to work side by side and build open solutions that can easily fit into complex heterogeneous environments. But while some in the industry do little more than talk about their commitment to collaboration and openness, we’re continually proving it. Now, trials like this are making the value of our approach abundantly clear.”

“As the leading provider of open network solutions to Tier 1 operators worldwide, and the leading contributor to the OCP, ONF, and TIP open communities, Edgecore understands the requirement to accelerate the innovation of disaggregated open network deployments while moving toward a more consistent and open infrastructure across mobile broadband and transport networks,” noted George Tchaparian, CEO and president, Edgecore Networks. “This successful live trial in Romania is yet another proof point that open networking is robust and deployable in the most demanding network environments.”


About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/pages/ADVA-Optical-Networking/37630238931

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting konsoliderer sit udbud inden for digital transformation med tilføjelsen af Internet & Idee22.1.2026 14:04:00 CET | Pressemeddelelse

Andersen Consulting indgår en samarbejdsaftale med Internet & Idee, et italiensk digitalt konsulentbureau, og styrker dermed sin evne til at levere integrerede, teknologidrevne løsninger. Internet & Idee blev stiftet i 1998 og specialiserer sig i digital strategi, softwareudvikling, test og kvalitetssikring, e-handel og mobile løsninger. Virksomheden opererer inden for to kerneområder: It-konsulentydelser og egne SaaS-produkter, herunder værktøjer til kreditstyring og cybersikkerhed. Med dyb ekspertise inden for bankvæsen, forsikring, kreditstyring og logistik for e-handel kombinerer Internet & Idee brancheindsigt med teknisk innovation med henblik på at drive forretningsresultater. "Dette samarbejde giver os mulighed for at anvende vores digitale ekspertise og branchekendskab i større skala," udtaler Carlo Stumpo, administrerende direktør for Internet & Idee. "Sammen med Andersen Consulting kan vi levere mere målrettede og effektive løsninger til kunder, der står over for komplekse ud

Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer22.1.2026 14:00:00 CET | Press release

Data demonstrate a 35 percent reduction in the risk of death Both dual primary endpoints (progression-free and overall survival) were met, without the need for biomarker selection and without increased safety burden Relacorilant’s New Drug Application (NDA) is under review by the U.S. Food and Drug Administration (FDA) as a treatment for patients with platinum-resistant ovarian cancer with a Prescription Drug User Fee Act (PDUFA) target action date of July 11, 2026 Relacorilant’s Marketing Authorization Application (MAA) for patients with platinum-resistant ovarian cancer is also under review by the European Medicines Agency (EMA) Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that ROSELLA, the company’s pivotal Phase 3 trial of relacorilant plus nab-paclitax

ExaGrid Announces All Flash/SSD Tiered Backup Storage Solution22.1.2026 14:00:00 CET | Press release

ExaGrid’s new solution offers the fastest, most scalable, and most secure backups in the industry ExaGrid®, the industry’s only Tiered Backup Storage solution with AI-Powered Retention Time-Lock (RTL) that includes a non-network-facing tier (tiered air gap), Auto Detect & Guard, delayed deletes and immutability for ransomware recovery, today announced that it is shipping an All Flash/SSD backup storage solution with a unique front-end Landing Zone and non-network-facing Repository Tier (tiered air gap) that stores all backup retention using advanced data deduplication. The new SSD appliances ship with ExaGrid software version 8. ExaGrid’s unique Landing Zone and scale-out architecture allow for significantly faster backups and restores, as well as scalability as data grows, versus other SSD products such as Dell Data Domain inline deduplication appliances with SSD or straight SSD from Pure Storage. Due to three years of software work and the extremely fast performance of SSD, ExaGrid’s

Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis22.1.2026 14:00:00 CET | Press release

New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker™. The new functionality complements Parse’s existing portfolio of Evercode immune products to enable a full end-to-end workflow for researchers. Immunologists have lacked an integrated, purpose-built platform capable of connecting immune repertoire data with whole transcriptome single cell insights. As a result, interpreting clonal behavior, understanding functional cell states, and drawing meaningful biological conclusions has often required stitching together fragmented tools, custom code, or inconsistent visualization approaches. The new Trailmaker functionality directly addresses these challenges by provi

AMGTA Announces EOS as New Principal Member and Appoints Björn Hannappel to Board of Directors22.1.2026 13:59:00 CET | Press release

The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in the association to Principal Member. As part of this expanded leadership role, Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121601881/en/ Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors. Principal Membership represents AMGTA’s highest level of engagement and is reserved for organizations demonstrating sustained leadership, strategic alignment, and a commitment to advancing sustainable and resilient manufacturing practices globally. As a Principal Member, EOS will take on an expanded role in shaping AMGTA’s strategic direction, governance, and industry collaboration initiatives. EOS is a world-leading technology supplier in the field of commercial 3D printing of meta

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye